|
|
||||||||
The University of Chicago, Pulmonary and Critical Care Medicine, Chicago, Illinois 60637
| |
ABSTRACT |
|---|
|
|
|---|
Hypoxia elicits a variety of adaptive responses at the tissue level, at the cellular level, and at the molecular level. A physiological response to hypoxia requires the existence of an O2 sensor coupled to a signal transduction system, which in turn activates the functional response. Although much has been learned about the signaling systems activated by hypoxia, no consensus exists regarding the nature of the underlying O2 sensor or whether multiple sensors exist. Among previously considered mechanisms, heme proteins have been suggested to undergo allosteric modification in response to O2 binding or release at different PO2 levels. Other studies suggest that ion channels may change conductance as a function of PO2, allowing them to signal the onset of hypoxia. Still other studies suggest that NADPH oxidase may decrease its generation of reactive O2 species (ROS) during hypoxia. Recent data suggest that mitochondria may function as O2 sensors by increasing their generation of ROS during hypoxia. These oxidant signals appear to act as second messengers in the adaptive responses to hypoxia in a variety of cell types. Such observations contribute to a growing awareness that mitochondria do more than just generate ATP, in that they initiate signaling cascades involved in adaptive responses to hypoxia and that they participate in the control of cell death pathways.
hypoxia; reactive oxygen species; NADPH; erythropoietin; hypoxia-inducible factor-1
| |
INTRODUCTION |
|---|
|
|
|---|
ADAPTATION TO HYPOXIA INVOLVES a wide range of responses that occur at different organizational levels in the body. At the organismal level, for example, the increase in alveolar ventilation that occurs during environmental hypoxia involves the interaction of chemoreceptors, the respiratory control centers in the medulla, and the respiratory muscles and lung/chest wall systems. At the tissue level, for example, pulmonary vascular smooth muscle cells constrict during alveolar hypoxia in a response referred to as hypoxic pulmonary vasoconstriction. By increasing vascular resistance, this response tends to divert blood away from the lung during in utero development and tends to optimize the matching of blood flow to alveolar ventilation after birth and during adulthood. At the cellular level, a number of well-documented responses to hypoxia can be seen. These include the release of neurotransmitters by the glomus cells of the carotid body, secretion of the hormone erythropoietin by cells of the kidney and liver, and the release of vascular growth factors by parenchymal cells in many tissues. In each of these examples, the initiation of the response to hypoxia requires the existence of a fundamental cellular O2-sensing mechanism that detects the fall in PO2 and initiates a signal transduction sequence that culminates in the activation of the particular functional response. The molecular identity of the cellular O2 sensor in each of the above responses has long been sought, and a large number of putative O2-sensing mechanisms have been proposed. However, despite considerable progress in our understanding of the pathways that are activated during cellular hypoxia, no consensus has been reached regarding the mechanism by which O2 sensing is achieved. Moreover, debate continues regarding the possible overlap in sensing mechanisms that are involved among the diverse functional responses in different cell types. Recent reviews have provided an excellent comprehensive summary of evidence supporting different mechanisms of O2 sensing in systems ranging in complexity from gram-negative bacteria up to mammalian cells (1, 8, 31, 49, 54). The diversity of viewpoints presented in these reviews is a testament to the absence of a consensus on the mechanisms of cellular O2 sensing in mammalian cells. This study prolongs this trend by providing a brief overview of a number of putative O2-sensing mechanisms and then proposing a novel mechanism based on work in our own laboratory.
| |
THE HEME-PROTEIN HYPOTHESIS FOR OXYGEN SENSING |
|---|
|
|
|---|
Much has been learned about the signal transduction sequences that are
activated during hypoxia and about the mechanisms responsible for
effecting the target responses. In the case of the erythropoietin gene,
our understanding of the transcriptional activation response to hypoxia
was advanced significantly with the identification of hypoxia-inducible
factor (HIF)-1 as the transactivator (61, 62). HIF-1 is a basic
helix-loop-helix member of the PAS family of transcription
factors, and its active form is a heterodimer comprised of
- and
-subunits (60). Although mRNA for both subunits can be detected
under normoxic conditions, the
-subunit is degraded rapidly by the
ubiquitin/proteasome breakdown pathway (29, 30). Consequently, Western
blotting analysis cannot detect the
-subunit during normoxia,
whereas the
-subunit is constitutively present (67). Under hypoxic
conditions, the
-subunit becomes stabilized, leading to dimer
formation, nuclear translocation, and DNA binding. These discoveries
have catalyzed a rapidly expanding understanding of additional HIF
family members, which appear to participate in a wide range of cellular
hypoxic responses. However, despite this growing understanding, the
mechanism responsible for the posttranslational stabilization of the
HIF-1
-subunit during hypoxia has not been established.
One long-held view has been that the O2 sensor responsible for initiating the erythropoietin transcriptional response to hypoxia involves a heme protein. According to that theory, hypoxia would be detected by an allosteric shift in a protein capable of reversibly binding O2 at a heme site. The idea is based on the observation that injection of cobalt chloride (CoCl2) induces erythropoietin secretion and polycythemia in rats (23) and that incubation of certain hepatoma cell lines (Hep 3B or Hep G2) with CoCl2 leads to a dose-dependent enhancement of erythropoietin mRNA levels under normoxic conditions (22). Goldberg and colleagues (22) proposed that Co2+ is incorporated into newly synthesized heme, thereby locking the O2 sensor into a deoxy configuration and so mimicking the effects of hypoxia. CO (10%), a physiologically stable molecule known to interact with heme groups, was found to inhibit the induction of erythropoietin induced during 1% O2. This was taken as further evidence for the involvement of a heme in the O2-sensing mechanism, presumably because CO shifted the protein to the oxy configuration. Finally, CO did not disrupt the induction of erythropoietin by Co2+, which was interpreted as further evidence for the heme hypothesis (22). One concern regarding the heme protein hypothesis arose with the report by Srinivas et al. (55), who found that inhibitors of heme synthesis failed to abolish the response to hypoxia in a reporter cell system. These observations do not rule out the possible involvement of a heme protein in the O2-sensing mechanism. However, they do raise questions about the possible role of Co2+ incorporation into newly synthesized heme. Conceivably, the O2 sensor could involve a heme-containing protein, but Co2+ could be acting on the signal transduction pathway downstream from that site.
| |
THE O2-SENSITIVE ION CHANNEL HYPOTHESIS |
|---|
|
|
|---|
In recent years, a number of reports have emerged suggesting that ion channels may be affected by local O2 levels, raising the possibility that these could function as O2 sensors in certain cell types. For example, in type I cells from the adult rabbit carotid body, Lopez-Barneo et al. (39) found that hypoxia could inhibit a K+ current. Subsequent studies have identified a wide range of different O2-sensitive ion channels that have been identified in different cell types (4, 40, 46).
Although it is now well established that certain ion channels adjust
their conductance properties in response to changes in PO2, it is less certain whether the
channels are themselves responsive to O2 or whether the
changes in conductance reflect a secondary response activated by a
separate, possibly nearby, O2 sensor. This possibility is
appealing because it could explain why such a diverse collection of ion
channels exhibit a sensitivity to O2, without the need to
postulate that a variety of O2-responsive subunits are
intrinsic to the channels. The notion that a nearby O2
sensor may be involved is supported by the observations that O2-sensitive channels are frequently responsive to
oxidizing and reducing agents. In this regard, Fearon et al. (20)
expressed an L-type Ca2+ channel
1c-subunit
in HEK-293 cells and found that whole cell patch-clamp recordings of
Ca2+ currents were inhibited by hypoxia. The oxidizing
agent p-chloromercuribenzenesulfonic acid abolished the
response to hypoxia, suggesting that hypoxia may affect channel
activity via redox modulation of specific thiol residues (20). The
ability to demonstrate O2-dependent channel gating in
experiments with isolated membrane patches tends to suggest the
involvement of a membrane-associated process (21). For example,
Perez-Garcia et al. (47) found that expression of Kv4.2 channels plus
KvB1.2 subunits in HEK-293 cells conferred sensitivity to redox
modulation and to low PO2.
Interestingly, membrane patches also demonstrated a change in
conductivity during 100% N2 exposure, which could indicate
either a direct effect of PO2 on the
channel or the involvement of a nearby membrane-associated
O2 sensor (47). Patel et al. (45) cotransfected COS cells
with Kv2.1 channels and the Kv9.3 subunit and found that channel
activity was inhibited by hypoxia but only in a subset of cells
studied. They concluded that the O2-sensing function was
not intrinsic to the Kv2.1-Kv9.4 complex, on the basis of the fact that
only some transfected cells responded to low O2 concentration (45). However, an alternative interpretation is based on
a recent report by Rustenbeck et al. (52), who found that mitochondria
were present in excised membrane patches from pancreatic
-cells. The
possibility that mitochondria may remain associated with ATP-sensitive
K+ (KATP) channels by being dragged into the
pipette during inside-out excised patch experiments raises the
possibility that such organelles could be involved in the
O2-sensing response. Because some membrane patches might
not contain these organelles, the hypoxic response might not be
observed in all experiments. This hypothesis is further fueled by their
observation that mitochondrial inhibitors can affect the
KATP channel behavior in those studies. Collectively, these
results are intriguing but will require further testing to determine
1) whether O2-sensitive channels respond in the
physiological range of hypoxia, 2) whether the modest changes
in gating seen at low PO2 can fully
explain the physiological response to hypoxia, and 3) whether
the O2 sensitivity is intrinsic to the channel or whether
the O2 sensor resides in organelles such as mitochondria
that may remain attached in excised patch experiments. In regard to
this last point, it would be useful to determine if a cloned
O2-sensitive channel protein retains its response to
hypoxia when inserted into a lipid bilayer, as that system would permit
a direct evaluation of the effects of hypoxia on the channel in the
absence of other potential O2-sensing systems.
| |
THE NAD(P)H OXIDASE HYPOTHESIS |
|---|
|
|
|---|
A number of investigators have suggested that a potential mechanism of O2 sensing could incorporate redox-dependent reactions involving members the NADPH oxidase family. This oxidase system is comprised of a multisubunit assembly consisting of a membrane-bound catalytic complex of gp91phox and p22phox subunits, which together form a flavo-cytochrome b558, and a cytosolic regulatory component consisting of p47phox, p67phox, and other regulatory subunits such as the GTPase proteins Rac-1 or Rac-2. At least in neutrophils, activation of the oxidase is regulated by the cytosolic components, which translocate to the membrane where they associate with cytochrome b558 and activate catalytic activity (15). According to the NADPH model of O2 sensing (24), electrons derived from NADPH are shuttled to O2 by the oxidase at a rapid rate during normoxia, generating superoxide. This would create a relatively oxidized redox state in the cytosol, caused by the relatively rapid rate of formation of reactive O2 species (ROS). Dismutation of superoxide would generate H2O2, which could be involved in local Fenton reactions at sites where ferrous iron is bound (18, 55), thereby inducing a site-specific oxidation of a regulatory protein. In either case, this model would require the catalytic subunits of the NADPH oxidase system to remain continuously activated during normoxia. During hypoxia, a decrease in the availability of O2 would lead to a slowed rate of electron transport through this system, resulting in a slowed rate of superoxide generation and a consequent shift in the cytosol redox to a more reduced state. Because the rate of ROS generation presumably would vary with the availability of O2, this system could effectively function as an O2 sensor. By generating ROS levels at a rate related to O2 concentration, such a system could also explain the changes in conductance of "O2-sensitive K+ channels" without the need to invoke a direct effect of O2 on the channel itself. In an O2-sensing system involving a membrane oxidase, hydrogen peroxide or superoxide could function as the second messenger linking the O2 sensor (the oxidase) to the target (nearby K+ channels) (59).
Evidence has emerged suggesting that subunit components of the NADPH oxidase system are expressed in a number of cells known to be O2 responsive. These include neuroepithelial bodies in the lung (68), type I cells of the carotid body (36), and pulmonary vascular myocytes (41). However, few studies directly implicate these systems in the O2-sensing function, and a number of studies point against their involvement. Patients with chronic granulomatous disease (CGD) suffer from a genetic defect in one or more of the subunits of NADPH oxidase. Loss of a subunit of that oxidase would abolish its activity and thereby abrogate the adaptive functions that depend on its participation. Patients with CGD are still able to maintain normal erythropoietin levels and can still respond to hypoxia, which suggests that NADPH oxidase function is not required for the O2 sensing underlying erythropoietin expression. Wenger et al. (65) showed that CGD-derived cell lines deficient in either the p22phox or gp91phox subunits were still able to express vascular endothelial growth factor (VEGF) and aldolase mRNA during 1% O2 compared with wild-type controls (65). These results further suggest that the NADPH oxidase system is not involved in the O2 sensing underlying erythropoietin expression. It could be argued that the O2 sensing in that response involves a different isoform of the NADPH oxidase, one not disrupted by CGD. However, a special concern relates to the effects of diphenyleneiodonium (DPI), an inhibitor of electron transport in a wide range of flavoprotein oxidases including NADPH oxidase. If hypoxia activates cellular responses via decreased ROS generation by an NADPH oxidase system, DPI should mimic the effects of hypoxia by suppressing ROS generation during normoxia. Although DPI has been shown to abolish the response to hypoxia, it does not mimic the hypoxic response during normoxia.
The NADPH oxidase model has also been invoked to explain the O2 sensing underlying hypoxic pulmonary vasoconstriction in the lung (41). According to that hypothesis, alveolar hypoxia should decrease the production of ROS by the NADPH oxidase system, causing a shift in cytosolic redox to a more reduced state in pulmonary artery smooth muscle cells. This redox shift would then lead to the inactivation of redox-dependent membrane K+ channels (2). The resulting membrane depolarization would then lead to opening of voltage-dependent Ca2+ channels, entry of Ca2+, and subsequent smooth muscle cell contraction. The current paradigm points to the probable involvement of one or more voltage-dependent K+ channels, based in part on the observation that nonspecific K+ channel inhibitors block the constriction elicited by hypoxia. In this system, the NADPH oxidase would function as the primary O2 sensor, whereas the membrane ion channels would function as the effectors of the vasoconstriction response (64).
Recently, Archer et al. (3) found that transgenic mice lacking the gp91phox subunit of the NADPH oxidase showed a decrease in the generation of ROS detected by lucigenin chemilumenescence at the lung surface. However, the whole cell K+ current response to hypoxia and the whole lung vasoconstrictor response to hypoxia were not inhibited. According to the NADPH oxidase model, the lack of a normally functioning oxidase system in knockout animals should mimic the redox changes normally associated with hypoxia. However, the pressure-flow relationships of the mutant mouse lungs were normal, and the responses to hypoxia were preserved, which does not fit with the model. Of course, it is possible that adaptive changes in the antioxidant systems of the knockout animal prevented such a response. However, as describe above, it is troublesome that DPI abolishes the response to hypoxia in lungs of normal animals (25, 69). Again, inhibition of the NADPH oxidase system by DPI should mimic the effects of hypoxia by limiting electron transfer through that oxidase. This would attenuate the ROS generation and associated redox changes during normoxia, resulting in a strong vasoconstrictor response. Although DPI blocks the vasopressor response to hypoxia, it does not cause sustained vasoconstriction during normoxia. Therefore, the findings of Archer et al. (3) would tend to rule out an NADPH-based mechanism as an O2 sensor underlying hypoxic pulmonary vasoconstriction.
| |
MITOCHONDRIAL HYPOTHESIS OF O2 SENSING |
|---|
|
|
|---|
Mitochondria have long been considered as potential sites of O2 sensing, based on the fact that they bind O2 and are responsible for the lion's share of O2 utilization in the cell. Detection of anoxia (PO2 = 0) by mitochondria is conceptually simple because electron transport and oxidative phosphorylation cease in the absence of O2. The resulting effects on cell function are profound, and one could argue that this represents an "O2 sensor-functional response" sequence. One might even argue that anoxic cell death represents an extreme case of this response pathway. However, a more difficult question relates to how mitochondria could detect differences in O2 tensions within the physiological range. One possible way to signal changes in O2 supply would be through changes in the redox state of the electron transport system or through effects on the earlier steps involved in the generation of reducing equivalents (i.e., NADH) in the Krebs cycle. Classic studies have shown that cellular respiration does not become O2 supply limited until the extracellular PO2 falls below 5-7 Torr (32, 33, 63, 66). The apparent Michaelis-Menten constant (Km) for O2 of cytochrome-c oxidase has been reported to be <1 µM, allowing state 3 respiration by mitochondria to remain independent of PO2 down to <2 Torr (12, 66). If electron transport is not limited by the O2 supply under hypoxia (PO2 = 5-50 Torr), it is difficult to understand how mitochondrial redox could be affected by O2 concentration. One possibility is that the "peri-mitochondrial PO2" in intact cells could be much lower than the extracellular PO2, due to O2 gradients between the plasma membrane and mitochondria. It has also been suggested that tissue-specific isoforms of the oxidase could exist with much higher apparent Km values (42); experimental evidence of this possibility has never emerged. In the case of the erythropoietin response, mitochondrial inhibitors such as cyanide have failed to abolish specific responses to hypoxia (43, 48), which suggests that mitochondrial electron transport must not be involved. However, in the case of the carotid body, it has long been known that cyanide can produce a potent stimulation. This and other observations have led some investigators to hypothesize that mitochondria are involved in the O2 transduction process in that organ (7). However, the apparent differences in responses to mitochondrial inhibitors in different O2-sensing systems have led to controversy regarding the role(s) that mitochondria play in the O2 sensing among different cell types (8). Of course, it is possible that mitochondria function in an O2-sensing capacity in some systems but not in others. In either case, an attractive feature of a mitochondrial role is that, by virtue of their existence in virtually all cells, they could potentially confer a universal sensitivity to O2 and explain the many similarities in the responses to low PO2 seen among many diverse cell types.
Recent studies from our laboratory point to a possible role of cytochrome oxidase in the response to hypoxia (5, 6, 10-12). Data suggest that, during hypoxia, the Vmax of the oxidase is reversibly decreased, whereas the apparent Km remains unchanged. The decrease in Vmax (~50%) does not directly limit normal respiration but does affect mitochondrial redox by requiring that the electron carriers operate in a more reduced state. This is manifested by a significant increase in the NADH concentration of the cell during moderate hypoxia (53). This adaptation in enzyme function appears to develop over 1-2 h in some cell types (11), whereas other cells undergo the change more rapidly (6). Interestingly, return of the enzyme to its "normoxic" state appears to occur rapidly on reoxygenation in all cell types. If this change in cytochrome oxidase function represents the primary O2 sensor, how is this signal transmitted throughout the cell? More recent evidence points to ROS as important elements in the signal transduction process.
| |
THE MITOCHONDRIA-DERIVED ROS HYPOTHESIS |
|---|
|
|
|---|
During mitochondrial respiration, O2 is chemically reduced to water by the transfer of four electrons at cytochrome oxidase. The resulting free energy change is conserved in the form of ATP synthesis. It has been estimated that 2-3% of the O2 consumed by mitochondria is incompletely reduced, yielding ROS (9). Univalent electron transfer to O2 generates superoxide, a modestly stable free radical anion. Superoxide can potentially be generated at a number of different sites, including complex I, the ubisemiquinone site of complex III, and other electron transfer proteins (56). ROS do not appear to be generated by cytochrome oxidase itself (19), due to the high-affinity kinetic trapping of O2 at the binuclear center, which occurs while the four electrons are sequentially transferred (58). The tendency for the electron transport chain to generate superoxide through promiscuous electron transfer to O2 depends on factors that include the availability of O2, the reduction state of the electron carriers, and the mitochondrial membrane potential (16, 35, 56, 57). It is conceivable that the decrease in cytochrome oxidase Vmax during hypoxia (11, 12) (see above) is responsible for an increase in mitochondrial redox state and that this in turn accelerates ROS generation during hypoxia. However, definitive evidence of this hypothesis has not been presented.
Recent data do suggest that ROS generated by mitochondria play a
physiological role in the cellular responses to hypoxia (13, 17). Like
nitric oxide, superoxide and hydrogen peroxide are moderately
stable reactants that are potentially useful as intracellular or even
intercellular signaling molecules. Using fluorescent dyes to detect an
oxidative signal, Duranteau and colleagues (17) studied the oxidation
of 2',7'-dichlorofluorescin (DCFH) in cardiomyocytes under
controlled O2 conditions (17). The cells were studied in a
flow-through chamber (0.5 ml) maintained at 37°C on an inverted microscope. The perfusate (1 ml/min) was bubbled with different O2 concentrations in a water-jacketed equilibration column
mounted above the microscope stage and was delivered to the chamber via a short length of tubing. The reduced diacetate form of the dye DCFH
was continually present in the medium (5 µM). Oxidation of the dye
within the cell yields the fluorescent compound
2',7'-dichlorofluorescein (DCF), which was detected with a
12-bit digital cooled charge-coupled device camera. In the absence of
dye, no fluorescence can be detected. After addition of dye to the
medium, evidence of cell fluorescence is detected within a few minutes.
Dye oxidized outside of the cell, or dye oxidized within the cell that
leaks out, is carried away in the perfusate flow. Under steady-state
conditions, cellular fluorescence reflects a balance between the rate
of oxidation of DCFH in the cell and the rate at which oxidized dye
escapes and is carried away. Paradoxically, oxidation of DCFH increased as the O2 concentration was decreased from normoxic levels
(16% O2), with minimal effects seen at 8% and a maximal
effect observed at 1% O2 (Fig.
1). Within minutes of decreasing the
O2 concentration, intracellular fluorescence increased,
reflecting an increase in the rate of dye oxidation. On return to
normoxia, fluorescence decreased as the rate of escape of oxidized dye
exceeds the rate of dye oxidation in the cell.
|
What causes oxidation of the dye? In vitro studies of DCFH suggest that H2O2 cannot directly oxidize the dye, whereas H2O2 addition to intact cells leads to rapid oxidation (27, 37, 50, 51). Studies indicate that DCFH is oxidized enzymatically in the cells via peroxidases that require H2O2 for the process (27). This suggests that DCFH oxidation can provide a sensitive measure of H2O2 generation in cells. There is no evidence to suggest that intracellular reductases can reduce the dye once it has been oxidized. Superoxide itself is not effective at oxidizing DCFH (37), although H2O2 generated by the dismutation of superoxide in cells can lead to rapid oxidation. Hydroxyl radical produced by H2O2 in the presence of ferrous iron can also oxidize the dye (37), as can nitric oxide (26). Regardless of the precise mechanism of dye oxidation, the appearance of cellular fluorescence reflects the rate of accumulation of DCF, which is a rather indirect measure of the rate of ROS generation. In a cell type that responds rapidly to hypoxia such as the carotid body, an immediate increase in DCF fluorescence would not be predicted even if ROS generation increased rapidly, due to the need to accumulate sufficient levels of oxidized dye to be able to detect a change in fluorescence. Because of its potential oxidation by a number of different mechanisms, the DCFH oxidation during hypoxia is, by itself, insufficient to demonstrate that the O2-sensing pathway involves ROS generation. Ultimately, the role of mitochondrial oxidants in the signaling activated by hypoxia needs to be tested by other approaches, to determine whether the functional responses to hypoxia also appear to depend on oxidant signaling pathways originating in the mitochondria.
The observation that DCFH oxidation increases during hypoxia suggested
that an oxidant stress is generated at low
PO2, although the source of the ROS
was not initially clear. To determine whether mitochondria were
responsible for the oxidant signal seen during hypoxia in Hep 3B cells,
which secrete erythropoietin during hypoxia, studies were carried out
using inhibitors of electron transfer (13). As seen with
cardiomyocytes, hypoxia increased DCFH oxidation in Hep 3B cells, with
the greatest increases seen at the lowest
PO2 levels (1% O2) (13).
The antioxidant ebselen, a glutathione peroxidase mimetic, abolished
the DCFH response to hypoxia, presumably by enhancing the scavenging of H2O2. (Fig.
2A) The antioxidant
pyrrolidinedithiocarbamate (PDTC), a thiol reductant, similarly
attenuated oxidant signaling. Addition of DPI to Hep 3B cells also led
to an attenuation of fluorescence, suggesting that a flavin-containing
electron carrier was required (Fig. 2B). However, a large
number of oxiodo-reductase systems utilize flavin groups, including
mitochondrial complex I, NADPH oxidase, and nitric oxide synthase (28,
38, 44). Hence, DPI is not useful in identifying the source of the
oxidant signal. Rotenone, a selective inhibitor of mitochondrial
complex I, caused a decrease in DCF fluorescence, suggesting that the
rate of oxidation had decreased (Fig. 2C) (13, 17). From this,
it can be inferred that the oxidation of DCFH requires electron
transport in the proximal region of the mitochondrial electron
transport chain. Myxothiazol is an inhibitor of electron transfer to
the Rieske iron-sulfur center of the mitochondrial bc1 complex, and
this compound similarly attenuated DCFH oxidation during hypoxia.
|
These data are compatible with the O2-sensing model
depicted in Fig. 3. During normal
mitochondrial respiration, reducing equivalents generated in aerobic
glycolysis or in the Krebs cycle are passed along a chain of electron
acceptors with progressively greater oxidation-reduction potentials. At
complexes I, III, and IV, the free energy released is captured and
utilized to extrude a proton from the mitochondrial matrix into the
intermembrane space. This process generates an electrochemical
potential across the inner mitochondrial membrane, which is used by the
F0F1 ATP synthase for the generation of ATP
from ADP and Pi. In the bc1 complex, ubiquinol becomes
oxidized to ubisemiquinone as it passes an electron to the Rieske
iron-sulfur center. Ubisemiquinone is a free radical that can transfer
an electron to molecular O2, yielding superoxide. The
generation of superoxide likely represents a balance between the
availability of O2 and the size of the ubisemiquinone pool
(56). Inhibitors that block electron transfer upstream from that site
(DPI, rotenone, myxothiazol, Amytal) tend to prevent the formation of
ubisemiquinone and thereby diminish ROS generation. Mitochondrial
inhibitors that act at more downstream sites tend to augment ROS
generation by increasing the generation of ubisemiquinone. For example,
cyanide and azide, which inhibit electron transfer by cytochrome
oxidase, tend to augment ROS generation by mitochondria. Likewise,
antimycin A augments ROS generation by inhibiting electron transfer at
the downstream end of the bc1 complex (Fig. 2D). Thus, although
a number of different mitochondrial inhibitors all block electron
transport, they exhibit differential effects on ROS generation depending on their site of action relative to the ubisemiquinone step.
To the extent that cytochrome oxidase functions as the ultimate O2 transducer in this response (12), the hypoxia-mediated
changes in its function could explain the changes in mitochondrial
redox responsible for changes in superoxide generation at the
ubisemiquinone step. However, it is also possible that superoxide
generation by ubisemiquinone is regulated directly by O2
concentration.
|
To approach this problem using a genetic tool, we generated
0 cells, a functional mitochondria-deficient cell line.
Rapidly dividing cells can be mutated into a
0 state by
incubation with ethidium bromide, which inhibits the replication of
mitochondrial DNA that is required for critical subunits of certain
mitochondrial electron transport complexes and for part of the
F0F1 ATP synthase. The
0 cells
are therefore incapable of supporting mitochondrial respiration or
oxidative phosphorylation. Survival and growth of
0
cells requires glycolytically derived ATP (34). Because
0 cells lack mitochondrial electron transport, they
provide insight into mechanisms requiring mitochondrial redox changes
or requiring the generation of mitochondrial ROS (14). In
0 Hep 3B cells, hypoxia failed to stimulate oxidative
signaling, as evidenced by an absence of DCFH oxidation (Fig.
4A) (13). How does
CoCl2 mimic the effects of hypoxia? Studies with DCFH dye
suggest that Co2+ augment ROS generation to an extent that
mimics the response during hypoxia (Fig. 4B). Interestingly,
although
0 Hep 3B cells failed to increase ROS
generation during hypoxia, they retained the ability to generate ROS
during Co2+ treatment, suggesting that CoCl2
mimics hypoxia by stimulating ROS generation via a nonmitochondrial
pathway (Fig. 4C). Ebselen and PDTC blocked the response to
Co2+ treatment in
0 cells, suggesting that
Co2+ was generating an oxidant signal.
|
The physiological significance of the above signaling system can be
seen in the regulation of gene expression of erythropoietin and VEGF
during hypoxia. Wild-type Hep 3B cells activate mRNA expression during
hypoxia or in response to CoCl2 (100 µM) during normoxia
(Fig. 5A) (13). The mitochondrial
inhibitors DPI, myxothiazol, and rotenone abolished the mRNA message
and DNA binding of HIF-1 in response to hypoxia, consistent with a role
of mitochondria in the response (13). The antioxidant ebselen, a
glutathione peroxidase mimetic, and PDTC, a metal chelator, both
abolished the response to hypoxia, presumably by enhancing the
scavenging of H2O2. During normoxia,
CoCl2 treatment activated the erythropoietin mRNA message
and antioxidants abolished this response. However, mitochondrial
inhibitors were ineffective in blocking the response to
Co2+, which is consistent with the involvement of a
nonmitochondrial ROS generating mechanism with Co2+. In
0 cells, the response to hypoxia was absent but the
response to CoCl2 was retained, which again was consistent
with a mitochondrial sensing mechanism (Fig. 5B). Collectively,
these results suggest that hypoxia-induced increases in mitochondrial
ROS are required for the activation of HIF-1.
|
Clearly, many questions remain regarding the mechanisms by which mitochondria contribute to the process of O2 sensing. The story of how mitochondrial oxidants may participate in the O2-sensing response is not yet complete, and additional work must be done to clarify the underlying mechanisms of that system and the extent to which it may function in diverse systems ranging from the carotid body to the Hep 3B cell. A recent resurgence of interest in mitochondria has occurred over the past several years with the realization that, in addition to being the major supplier of ATP, mitochondria play an important role in signal transduction, including the early events of apoptosis, and in glucose sensing in pancreatic islet cells. The possibility that mitochondria may also function as a site of O2 sensing is an exciting one, for it opens the door to the suggestion that many of the diverse cellular responses to hypoxia may involve this interesting organelle.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-32646 and HL-35440. N. S. Chandel was supported by a Senior Fellowship from the American Lung Association.
| |
FOOTNOTES |
|---|
First in a series of invited mini-reviews on "Hypoxia Influence on Gene Expression."
Address for reprint requests and other correspondence: P. T. Schumacker, Dept. of Medicine MC6026, 5841 South Maryland Ave., Chicago, IL 60637 (E-mail: pschumac{at}medicine.bsd.uchicago.edu).
| |
REFERENCES |
|---|
|
|
|---|
1.
Acker, H.
PO2 affinities, heme proteins, and reactive oxygen intermediates involved in intracellular signal cascades for sensing oxygen.
Adv Exp Med Biol
410:
59-64,
1996[Medline].
2.
Archer, SL,
Huang J,
Henry T,
Peterson D,
and
Weir EK.
A redox-based O2 sensor in rat pulmonary vasculature.
Circ Res
73:
1100-1112,
1993
3.
Archer, SL,
Reeve HL,
Michelakis E,
Puttagunta L,
Waite R,
Nelson DP,
Dinauer MC,
and
Weir EK.
O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase.
Proc Natl Acad Sci USA
96:
7944-7949,
1999
4.
Buckler, KJ.
A novel oxygen-sensitive potassium current in rat carotid body type I cells.
J Physiol (Lond)
498:
649-662,
1997[ISI][Medline].
5.
Budinger, GRS,
Chandel N,
Shao ZH,
Li CQ,
Melmed A,
Becker LB,
and
Schumacker PT.
Cellular energy utilization and supply during hypoxia in embryonic cardiac myocytes.
Am J Physiol Lung Cell Mol Physiol
270:
L37-L53,
1996
6.
Budinger, GRS,
Duranteau J,
Chandel NS,
and
Schumacker PT.
Hibernation during hypoxia in cardiomyocytes: role of mitochondria as the O2 sensor.
J Biol Chem
273:
3320-3326,
1998
7.
Buerk, DG,
Iturriaga R,
and
Lahiri S.
Testing the metabolic hypothesis of O2 chemoreception in the cat carotid body in vitro.
J Appl Physiol
76:
1317-1323,
1994
8.
Bunn, HF,
and
Poyton RO.
Oxygen sensing and molecular adaptation to hypoxia.
Physiol Rev
76:
839-885,
1996
9.
Chance, B,
and
Williams GR.
Respiratory enzymes in oxidative phosphorylation.
J Biol Chem
217:
383-393,
1955
10.
Chandel, NS,
Budinger GRS,
Choe SH,
and
Schumacker PT.
Cellular respiration during hypoxia: role of cytochrome oxidase as the oxygen sensor in hepatocytes.
J Biol Chem
272:
111-112,
1997.
11.
Chandel, N,
Budinger GRS,
Kemp RA,
and
Schumacker PT.
Inhibition of cytochrome-c oxidase activity during prolonged hypoxia.
Am J Physiol Lung Cell Mol Physiol
268:
L918-L925,
1995
12.
Chandel, NS,
Budinger GRS,
and
Schumacker PT.
Molecular oxygen modulates cytochrome c oxidase function.
J Biol Chem
271:
18672-18677,
1996
13.
Chandel, NS,
Maltepe E,
Goldwasser E,
Mathieu CE,
Simon MC,
and
Schumacker PT.
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.
Proc Natl Acad Sci USA
95:
11715-11720,
1998
14.
Chandel, NS,
and
Schumacker PT.
Cells depleted of mitochondrial DNA (
0) yield insight into physiological mechanisms.
FEBS Lett
454:
173-176,
1999[ISI][Medline].
15.
Cross, AR,
Erickson RW,
and
Curnutte JT.
The mechanism of activation of NADPH oxidase in the cell-free system: the activation process is primarily catalytic and not through the formation of a stoichiometric complex.
Biochem J
341:
251-255,
1999.
16.
Dawson, TL,
Gores GJ,
Nieminen AL,
Herman B,
and
Lemasters JJ.
Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes.
Am J Physiol Cell Physiol
264:
C961-C967,
1993
17.
Duranteau, J,
Chandel NS,
Kulisz A,
Shao Z,
and
Schumacker PT.
Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes.
J Biol Chem
273:
11619-11624,
1998
18.
Ehleben, W,
Porwol T,
Fandrey J,
Kummer W,
and
Acker H.
Cobalt and desferrioxamine reveal crucial members of the oxygen sensing pathway in HepG2 cells.
Kidney Int
51:
483-491,
1997[ISI][Medline].
19.
Fabian, M,
and
Palmer G.
Hydrogen peroxide is not released following reaction of cyanide with several catalytically important derivatives of cytochrome c oxidase.
FEBS Lett
422:
1-4,
1998[ISI][Medline].
20.
Fearon, IM,
Palmer AC,
Balmforth AJ,
Ball SG,
Varadi G,
and
Peers C.
Modulation of recombinant human cardiac L-type Ca2+ channel
1C subunits by redox agents and hypoxia.
J Physiol (Lond)
514:
629-637,
1999
21.
Ganfornina, MD,
and
Lopez-Barneo J.
Single K+ channels in membrane patches of arterial chemoreceptor cells are modulated by O2 tension.
Proc Natl Acad Sci USA
88:
2927-2930,
1991
22.
Goldberg, MA,
Dunning SP,
and
Bunn HF.
Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein.
Science
242:
1412-1415,
1988
23.
Goldwasser, E,
Jacobson LO,
Fried W,
and
Plzak LF.
The effect of cobalt on the production of erythropoietin.
Studies Erythropoiesis
13:
55-60,
1958.
24.
Gorlach, A,
Holtermann G,
Jelkmann W,
Hancock JT,
Jones SA,
Jones OT,
and
Acker H.
Photometric characteristics of haem proteins in erythropoietin-producing hepatoma cells (HepG2).
Biochem J
290:
771-776,
1993.
25.
Grimminger, F,
Weissmann N,
Spriestersbach R,
Becker E,
Rosseau S,
and
Seeger W.
Effects of NADPH oxidase inhibitors on hypoxic vasoconstriction in buffer-perfused rabbit lungs.
Am J Physiol Lung Cell Mol Physiol
268:
L747-L752,
1995
26.
Gunasekar, PG,
Kanthasamy AG,
Borowitz JL,
and
Isom GE.
Monitoring intracellular nitric oxide formation by dichlorofluorescin in neuronal cells.
J Neurosci Methods
61:
15-21,
1995[ISI][Medline].
27.
Hockberger, PE,
Skimina TA,
Centonze VE,
Lavin C,
Chu S,
Dadras S,
Reddy JK,
and
White JG.
Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells.
Proc Natl Acad Sci USA
96:
6255-6260,
1999
28.
Holland, PC,
Clark MG,
Bloxham DP,
and
Lardy HA.
Mechanism of action of the hypoglycemic agent diphenyleneiodonium.
J Biol Chem
248:
6050-6056,
1973
29.
Huang, LE,
Arany Z,
Livingston DM,
and
Bunn HF.
Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its
subunit.
J Biol Chem
271:
32253-32259,
1996
30.
Huang, LE,
Gu J,
Schau M,
and
Bunn HF.
Regulation of hypoxia-inducible factor 1
is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.
Proc Natl Acad Sci USA
95:
7987-7992,
1998
31.
Huang, LE,
Ho V,
Arany Z,
Krainc D,
Galson D,
Tendler D,
Livingston DM,
and
Bunn HF.
Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors.
Kidney Int
51:
548-552,
1997[ISI][Medline].
32.
Jones, DP,
and
Mason HS.
Gradients of O2 concentration in hepatocytes.
J Biol Chem
253:
4874-4880,
1978
33.
Kennedy, FG,
and
Jones DP.
Oxygen dependence of mitochondrial function in isolated rat cardiac myocytes.
Am J Physiol Cell Physiol
250:
C374-C383,
1986
34.
King, MP,
and
Attardi G.
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.
Science
246:
500-503,
1989
35.
Korshunov, SS,
Skulachev V,
and
Starkov AA.
High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria.
FEBS Lett
416:
15-18,
1997[ISI][Medline].
36.
Kummer, W,
and
Acker H.
Immunohistochemical demonstration of four subunits of neutrophil NAD(P)H oxidase in type I cells of carotid body.
J Appl Physiol
78:
1904-1909,
1995
37.
LeBel, CP,
Ischiropoulos H,
and
Bondy SC.
Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress.
Chem Res Toxicol
5:
227-231,
1992[ISI][Medline].
38.
Li, Y,
and
Trush MA.
Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production.
Biochem Biophys Res Commun
253:
295-299,
1998[ISI][Medline].
39.
Lopez-Barneo, J,
Lopez-Lopez JR,
Urena J,
and
Gonzalez C.
Chemotransduction in the carotid body: K+ current modulated by PO2 in type I chemoreceptor cells.
Science
241:
580-582,
1988
40.
Lopez-Barneo, J,
Ortega-Sanez P,
Mokina A,
Franco-Obregon A,
Urena J,
and
Castellano A.
Oxygen sensing by ion channels.
Kidney Int
51:
454-461,
1997[ISI][Medline].
41.
Marshall, C,
Mamary AJ,
Verhoeven AJ,
and
Marshall BE.
Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction.
Am J Respir Cell Mol Biol
15:
633-644,
1996[Abstract].
42.
Mills, E,
and
Jobsis FF.
Mitochondrial respiratory chain of carotid body and chemoreceptor response to changes in oxygen tension.
J Neurophysiol
35:
405-428,
1972
43.
Necas, E,
and
Neuwirt J.
The effect of inhibitors of energy metabolism on erythropoietin production.
J Lab Clin Med
79:
388-396,
1972[ISI][Medline].
44.
Okun, JG,
Lummen P,
and
Brandt U.
Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase).
J Biol Chem
274:
2625-2630,
1999
45.
Patel, AJ,
Lazdunski M,
and
Honore E.
Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes.
EMBO J
16:
6615-6625,
1997[ISI][Medline].
46.
Peers, C,
and
Buckler KJ.
Trasnduction of chemostimuli by the type I carotid body cell.
J Membr Biol
144:
1-9,
1995[ISI][Medline].
47.
Perez-Garcia, MT,
Lopez-Lopez JR,
and
Gonzalez C.
Kvbeta1.2 subunit coexpression in HEK293 cells confers O2 sensitivity to Kv4.2 but not to Shaker channels.
J Gen Physiol
113:
897-907,
1999
48.
Pugh, CW,
Tan CC,
Jones RW,
and
Ratcliffe PJ.
Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene.
Proc Natl Acad Sci USA
88:
10553-10557,
1991
49.
Ratcliffe, PJ,
Maxwell PH,
and
Pugh CW.
Beyond erythropoietin: the oxygen sensor.
Nephrol Dial Transplant
12:
1842-1848,
1997
50.
Rothe, G,
and
Valet G.
Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin.
J Leukoc Biol
47:
440-448,
1990[Abstract].
51.
Royall, JA,
and
Ischiropoulos H.
Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells.
Arch Biochem Biophys
302:
348-355,
1993[ISI][Medline].
52.
Rustenbeck, I,
Dickel C,
Herrmann C,
and
Grimmsmann T.
Mitochondria present in excised patches from pancreatic B-cells may form microcompartments with ATP-dependent potassium channels.
Biosci Rep
19:
89-98,
1999[ISI][Medline].
53.
Schumacker, PT,
Chandel N,
and
Agusti AGN
Oxygen conformance of cellular respiration in hepatocytes.
Am J Physiol Lung Cell Mol Physiol
265:
L395-L402,
1993
54.
Semenza, GL.
Perspectives on oxygen sensing.
Cell
98:
281-284,
1999[ISI][Medline].
55.
Srinivas, V,
Zhu X,
Salceda S,
Nakamura R,
and
Caro J.
Hypoxia-inducible factor 1
(HIF-1
) is a non-heme iron protein.
J Biol Chem
273:
18019-18022,
1998
56.
Turrens, JF,
Alexandre A,
and
Lehninger AL.
Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria.
Arch Biochem Biophys
237:
408-414,
1985[ISI][Medline].
57.
Turrens, JF,
and
Boveris A.
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.
Biochem J
191:
421-427,
1980[ISI][Medline].
58.
Verkhovsky, MI,
Morgan JE,
Puustinen A,
and
Wikström M.
Kinetic trapping of oxygen in cell respiration.
Nature
380:
268-270,
1996[Medline].
59.
Wang, D,
Youngson C,
Wong V,
Yeger H,
Dinauer MC,
Vega-Saenz ME,
Rudy B,
and
Cutz E.
NADPH-oxidase and a hydrogen peroxide-sensitive K+ channel may function as an oxygen sensor complex in airway chemoreceptors and small cell lung carcinoma cell lines.
Proc Natl Acad Sci USA
93:
13182-13187,
1996
60.
Wang, GL,
Jiang B-H,
Rue EA,
and
Semenza GL.
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
Proc Natl Acad Sci USA
92:
5510-5514,
1995
61.
Wang, GL,
and
Semenza GL.
Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.
Blood
82:
3610-3615,
1993
62.
Wang, GL,
and
Semenza GL.
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Proc Natl Acad Sci USA
90:
4304-4308,
1993
63.
Warburg, O,
and
Kubowitz F.
Atmung bei sehr kleinen Sauerstoffdrucken.
Biochem Z
214:
5-18,
1929.
64.
Weir, EK,
and
Archer SL.
The mechanism of acute hypoxic pulmonary vasoconstriction: a tale of two channels.
FASEB J
9:
183-189,
1995[Abstract].
65.
Wenger, RH,
Marti HH,
Schuerer-Maly CC,
Kvietikova I,
Bauer C,
Gassmann M,
and
Maly FE.
Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.
Blood
87:
756-761,
1996
66.
Wilson, DF,
Rumsey WL,
Green TJ,
and
Vanderkooi JM.
The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration.
J Biol Chem
263:
2712-2718,
1988
67.
Wood, SM,
Gleadle JM,
Pugh CW,
Hankinson O,
and
Ratcliffe PJ.
The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells.
J Biol Chem
271:
15117-15123,
1996
68.
Youngson, C,
Nurse C,
Yeger H,
and
Cutz E.
Oxygen sensing in airway chemoreceptors.
Nature
365:
153-155,
1993[Medline].
69.
Zhang, F,
Carson RC,
Zhang H,
Gibson G,
and
Thomas HM.
Pulmonary artery smooth muscle cell [Ca2+]i and contraction: responses to diphenyleneiodonium and hypoxia.
Am J Physiol Lung Cell Mol Physiol
273:
L603-L611,
1997
This article has been cited by other articles:
![]() |
H. S. Kim, P. A. Loughran, J. Rao, T. R. Billiar, and B. S. Zuckerbraun Carbon monoxide activates NF-{kappa}B via ROS generation and Akt pathways to protect against cell death of hepatocytes Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G146 - G152. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Prentice Key contributions of the Na+/H+ exchanger subunit 1 and HCO3- transporters in regulating neuronal cell fate in prolonged hypoxia Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R448 - R450. [Full Text] [PDF] |
||||
![]() |
M. F. Essop Cardiac metabolic adaptations in response to chronic hypoxia J. Physiol., November 1, 2007; 584(3): 715 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Dada, E. Novoa, E. Lecuona, H. Sun, and J. I. Sznajder Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na,K-ATPase in A549 cells J. Cell Sci., July 1, 2007; 120(13): 2214 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |